ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: David Harrington Replaces Zelen At ECOG; Kushnet To Receive Ewing Layman’s Award

December 1, 1989

Abstracts Of Papers From Conference On Adjuvant Therapy

April 22, 1977

Cancer Mmeetings Lister For Next Three Months

February 23, 1996

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995

ASCO Updates Guideline On Follow-Up Management

October 27, 2006